Countries covered: Global
This report analyzes the Global Market for Brachytherapy in Millions of US$. The ‘Brachytherapy’ market is analyzed in terms of the following product segments: Implantable Prostate Seeds Brachytherapy, and Post-Operative Brachytherapy. Annual forecasts are provided for the period of 2005 through 2015. The report profiles 38 companies including many key and niche players worldwide such as Best Medical International, Inc., Best Vascular, Inc., BrachySciences, Inc., Core Oncology, C. R. Bard, Inc., Cytyc Corporation, Eckert & Ziegler Strahlen- und Medizintechnik AG, International Brachytherapy SA, NAS Medical, Oncura, Inc., Sirtex Medical Ltd., Theragenics Corporation, Varian Medical Systems, Inc., and Xoft, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.
Adobe Acrobat Reader 7.0 is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.
Titles available via "online download" are not affected by this and are still delivered to your reading room immediately.
Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.
|
- I.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITION
- Study Reliability and Reporting Limitations
- Disclaimers
- Data Interpretation & Reporting Level
- Quantitative Techniques & Analytics
- Product Definition and Scope of Study
- Implantable Prostate Seeds Brachytherapy
- Post-Operative Brachytherapy
- II. EXECUTIVE SUMMARY
- 1.INDUSTRY OVERVIEW
- Cancer - A Major Health Concern
- Quick Cancer Statistics
- Table 1: Worldwide New Cancer Cases (2007) -Percentage Share Breakdown by Region (includes corresponding Graph/Chart)
- Table 2: Worldwide New Cancer Cases (2007) -Percentage Share by Region and Sex (includescorresponding Graph/Chart)
- Growing Cancer Cases in Developing Countries
- Table 3: Worldwide Cancer Causes (%) by Level of Economic Development (includes corresponding Graph/Chart)
- 2.BRACHYTHERAPY MARKET
- Brachytherapy - A Prelude
- Growth Driving Factors
- Brachytherapy Provides Hope for Cancer Patients
- Growing Brachytherapy Acceptance
- Aging Population: An Important Demographic Driver
- Prostate Brachytherapy Offers Bright Prospects
- Reimbursement Scenario
- Competition Heats Up in the Brachytherapy Market
- Macular Degeneration - An Emerging BrachytherapyApplication
- APBI Therapy Rise in Popularity
- Balloon Brachytherapy Gains Prominence
- 3.BRACHYTHERAPY - AN INTRODUCTION
- What is Brachytherapy?
- Implantable Prostate Seeds Brachytherapy
- Post-Operative Brachytherapy
- Mechanism of Action
- Brachytherapy - Under the Microscope
- Brachytherapy Sources
- The Team
- Historical Perspective
- Brachytherapy - A Classification
- Types As Per Seed Positioning
- Mold Brachytherapy
- Interstitial Brachytherapy
- Endovascular Brachytherapy
- Stent-Based Techniques
- Catheter-Based Techniques
- Intracavitary Brachytherapy
- Classification As Per Irradiation Duration
- Temporary Brachytherapy
- Permanent Brachytherapy
- Categorization As Per the Dose Rate
- HDR Brachytherapy
- LDR Brachytherapy
- PDR Brachytherapy
- PDR Brachytherapy Vs HDR Brachytherapy
- PDR Brachytherapy Vs LDR Brachytherapy
- 4.BRACHYTHERAPY EQUIPMENT
- Brachytherapy Systems
- Remote Afterloading Machines
- Manual Afterloading Machines
- Brachytherapy Applicators
- Types of Brachytherapy Applicators
- Automated Brachytherapy Applicators
- Manual Brachytherapy Applicators
- 5.PROSTATE CANCER - A MAJORBRACHYTHERAPY INDICATION
- Prostate Cancer - A Deadly Disease
- Brachytherapy Revolutionizes Prostate Cancer Treatment
- History Behind the Development
- Prostate Brachytherapy Procedure
- Seed Brachytherapy Clinical Outcomes
- Side Effects Do Exist
- Types of Brachytherapy Procedures for ProstateCancer Treatment
- Interstitial Brachytherapy
- Combination Radiotherapy
- Whole Pelvic Radiation Therapy
- Seed Migration - A Cause of Concern?
- 6.OTHER MAJOR BRACHYTHERAPYINDICATIONS
- Breast Cancer
- Breast Brachytherapy - An Introduction
- How is Breast Brachytherapy Performed?
- Breast Brachytherapy Techniques
- Brain Brachytherapy
- Brain Tumor
- Types of Brain Tumor
- Treatment Techniques
- Brain Brachytherapy
- Whole Brain Radiation Therapy
- Bronchial Carcinoma
- Bronchial Brachytherapy
- Procedure
- Head and Neck Brachytherapy
- Cervical Brachytherapy
- Esophageal Brachytherapy
- Brachytherapy for Eyelid Tumors
- Other Indications
- 7.RESEARCH/STUDY FINDINGS
- CyberKnife® Effective for HDR Brachytherapy
- SAVI Breast Brachytherapy Offers Enhanced DoseControl
- Electronic Brachytherapy Treats Early Stage BreastCancer
- Brachytherapy Treats Head And Neck Cancers
- Brachytherapy and External Radiation Therapy OfferImpressive Outcomes
- Brachytherapy Effective in Single Brain MetastasesTreatment
- MRI-based Brachytherapy Treats Cervical Cancer
- 8.PRODUCT INNOVATIONS/INTRODUCTIONS
- Varian Medical Systems Launch VariSeed 8.0
- Nucletron Introduces 3 New Brachytherapy Products
- Xoft to Launch Axxent Xpress™ Mobile ElectronicBrachytherapy Vehicles
- SenoRx Launches Contura Multi-Lumen Balloon Catheter
- BrachySciences Introduces TheraSeed® Palladium-103Isotope AnchorSeed
- Cianna Medical Launches New Version of SAVI™Applicator
- Nucletron Introduces Oncentra® Brachy Cancer TreatmentSolution
- Varian to Introduce New RapidArc RadiotherapyTechnology
- Prowess Launches Inverse Planning BrachytherapySystem
- IBA Introduces New COMPACT Proton TherapySystem
- Varian Introduces Brachytherapy Treatment PlanningSystem
- Nucletron Unveils IPSA for HDR Brachytherapy
- B-K Medical Introduces New Transducer
- FDA Approves NASI’s New Range of BrachytherapyOfferings
- NASI Launches ClearPath™
- BioLucent Launches Innovative SAVI Device for BreastBrachytherapy
- 9.RECENT INDUSTRY ACTIVITY
- IsoRay and BrachySciences Ink Distribution Agreement
- North American Scientific Agrees to Divest ProstateBrachytherapy Products
- IsoRay Receives Health Canada’s Approvalfor Selling Proxcelan Cs-131
- Nucletron Enters into Partnership with Isodose Control
- Xoft Gains FDA Approval for Applicators
- Varian Medical Collaborates with BK Medical
- Oncologix Inks MoU with IUT
- NeoVista Gains Approval from BSI Product Services
- Xoft and Elekta Inks an Agreement
- IsoRay Acquires Minority Stake in UralDial
- IBt-BEBIG Receives Supply Contract from HospitalUniversitario Ramón y Cajal
- Eckert & Ziegler to Supply Radiation Therapy Products toSpanish Hospitals
- North American Scientific Changes Name to NAS Medical
- Theragenics Acquires NeedleTech
- Implant to Divest IP and Medical Assets of BrachytherapyProducts Business
- IBt to Form Joint Venture with RNT and 000 Bebig
- Nucletron and AKH/MUW Extend Cooperation withMulti-Tiered Partnership
- IsoAid Secures 3-Year Contract for Supply ofBrachytherapy Products
- Envisioneering Inks Distribution Agreement withIsodose Control
- Biocompatibles Acquires BrachySciences
- Nucletron and BrachySolutions Form Partnership
- SIUT Inaugurates New Brachytherapy Center
- IBt to Acquire Brachytherapy Business Segments fromEZAG
- North American Scientific Enters into an Agreement with Carbon Medical
- Varian Receives FDA Approval for BrachytherapyApplicator
- IBt Completes Acquisition of Urorad
- IsoRay Inks an Agreement with Applied ProcessEngineering Laboratory
- International Brachytherapy Inks an Agreement with IBA
- IsoRay Medical Inks Letter of Intent with International Brachytherapy
- IsoRay Medical to Shift Production Facility to APELin Richland
- Radiation Therapy Services Acquires Radiation TherapyFacility
- Hologic Plans BioLucent Acquisition
- Core Oncology Acquires Mills Biopharmaceuticals
- International Isotopes Takes Over Minority Stakein RadQual
- ONCURA Inks Agreement with Premier
- MDS Nordion and Best Medical International Signan Agreement
- North American Scientific Divests NOMOS® to BestMedical International
- Premier Renews Contract with North American Scientific
- Sirtex Expands its Research and Development Program
- Xoft Axxent™ Electronic Brachytherapy System ReceivesFDA Approval
- North American Scientific Launches Initiative for BreastBrachytherapy
- Coloplast Acquires Urology Business Unit of Mentor
- Implant Sciences Signs an Agreement with InternationalBrachytherapy
- BrachySciences Enters into Distribution Agreementwith Envisioneering
- IBt Inks a Distribution Agreement with Isodose Control
- ONCURA Inks an Agreement with Novation and UHC
- ONCURA Inks an Agreement with HealthTrustPurchasing Group
- IsoRay Commences Cesium-131 Production Testing
- InterCommunity Cancer Center Offers Cesium-131for Prostrate Cancer
- 10.OTHER DEVELOPMENTS
- The U.S. Patent and Trademark Office Issues Patentsfor SAVI™
- Sirtex Obtains FDA Approval for Producing SIR-Spheres®Microspheres
- MDS Nordion Secures FDA Approval for TheraSphere®
- Health Commission Wales to Provide BrachytherapyServices in Wales
- IBt Receives Reimbursement for InterStrand-125and InterSource-125
- MDS Nordion Sets Up Centers of Excellence forTheraSphere®
- Aarhus University Hospital Begins Using IGBT
- WellStar Kennestone Hospital Acquires Axxent ElectronicBrachytherapy System
- Silicon Valley Urology Center Starts Using Cesium-131
- MDS Nordion Receives US FDA Approval toTest Efficacy of TheraSphere®
- ONCURA Bags Contract to Supply Seeds toThe Cookridge Hospital
- 11.FOCUS ON SELECT GLOBAL PLAYERS
- Best Medical International, Inc. (US)
- Best Vascular, Inc. (US)
- BrachySciences, Inc. (US)
- Core Oncology (US)
- C. R. Bard, Inc. (US)
- Cytyc Corporation (US)
- Eckert & Ziegler Strahlen- und Medizintechnik AG(Germany)
- International Brachytherapy SA (Belgium)
- NAS Medical (US)
- Oncura, Inc. (US)
- Sirtex Medical Ltd. (Australia)
- Theragenics Corporation (US)
- Varian Medical Systems, Inc. (US)
- Xoft, Inc. (US)
- III. MARKET
- 1.THE UNITED STATES
- A. Market Analysis
- Current & Future Analysis
- Cancer Presumes Epidemic Proportion
- A Glance at Cancer Statistics
- Table 4: Cancer-Affected Population in the US (2007): Percentage Share Breakdown by Cancer Type(includes corresponding Graph/Chart)
- Table 5: US New Cancer Cases (2008) - PercentageShare Breakdown by Leading State (includes corresponding Graph/Chart)
- Growing Cancer Prevalence Drives BrachytherapyDemand
- Brachytherapy - Effective Option for CancerTreatment
- Rapid Growth in Prostate Brachytherapy Market
- Leading Players
- Table 6: Leading Players in the US Implantable Seeds Brachytherapy Market (2009E): Percentage Share Breakdown of Sales for Oncura Corp., CR Bard, andOthers (includes corresponding Graph/Chart)
- Technology Advancements Accelerate Growth
- Breast Brachytherapy Witnesses Slow Growth
- Balloon Brachytherapy Making Inroads intoMainstream Market
- Competitive Scenario
- Table 7: US Balloon Brachytherapy Market (2008): Percentage Value Share Breakdown by Leading Company - Cytyc, SenoRx, and Xoft (includes corresponding Graph/Chart)
- Reimbursement Scenario
- Growth Drivers
- Positive Research Results Drive Acceptance ofBrachytherapy
- Market Consolidation Drives Growth
- New Developments Propel Market Growth
- Product Launches
- Strategic Corporate Developments
- Other Developments
- Key Players
- B. Market Analytics
- Table 8: US Recent Past, Current & Future Analysis for Brachytherapy: Annual Number of Implantable ProstateSeed and Post-Operative Brachytherapy Proceduresfor Years 2005 through 2015 (in Thousands)(includes corresponding Graph/Chart)
- Table 9: US 10-Year Perspective for Brachytherapy by Segment - Percentage Breakdown of ImplantableProstate Seed and Post-Operative BrachytherapyProcedures for Years 2006, 2009 & 2015
- Table 10: US Recent Past, Current & Future Analysis for Brachytherapy by Segment - Implantable Prostate Seedand Post-Operative Brachytherapy Procedures Markets Independently Analyzed with Annual Revenues inUS$ Million for Years 2005 through 2015(includes corresponding Graph/Chart)
- Table 11: US 10-Year Perspective for Brachytherapyby Segment - Percentage Breakdown of Revenues for Implantable Prostate Seed and Post-SurgicalBrachytherapy Markets for Years 2006, 2009 & 2015
- Table 12: US Recent Past, Current & Future Analysisfor Endovascular Brachytherapy Market with Annual Revenues in US$ Million for Years 2005 through2015 (includes corresponding Graph/Chart)
- 2.EUROPE
- A. Market Analysis
- Market Outlook
- Brachytherapy in Europe
- Seed Brachytherapy Market - An Overview
- Strategic Initiatives to Drive Growth
- Leading Players
- Table 13: Leading Players in the European Implantable Prostate Seeds Market (Iodine) (2009E): Percentage Breakdown of Value Sales for Oncura Corp.,C.R. Bard, and Others (includes corresponding Graph/Chart)
- Reimbursement Changes Accelerate RadiationSeed Sales
- Prostate Brachytherapy Gains Strength
- Prostate Seed Market
- An Overview
- Competitive Analysis
- Seed Pricing Analysis
- Table 14: Average Prices of Prostate BrachytherapySeeds for the years 2003 & 2010
- A Focus on the French Market
- UK Prostate Brachytherapy Market - An Overview
- Strategic Corporate Developments
- Key Players
- B. Market Analytics
- Table 15: European Recent Past, Current & Future Analysis for Brachytherapy: Annual Number of Implantable Prostate Seed and Post-Operative Brachytherapy Proceduresfor Years 2005 through 2015 (in Thousands)(includes corresponding Graph/Chart)
- Table 16: European 10-Year Perspective for Brachytherapy by Segment - Percentage Breakdown of ImplantableProstate Seed and Post-Operative BrachytherapyProcedures for Years 2006, 2009 & 2015
- Table 17: European Recent Past, Current & Future Analysis for Brachytherapy by Segment - Implantable Prostate Seed and Post-Operative Brachytherapy Procedures Markets Independently Analyzed with Annual Revenues in US$Million for Years 2005 through 2015 (includescorresponding Graph/Chart)
- Table 18: European 10-Year Perspective forBrachytherapy by Segment - Percentage Breakdownof Annual Revenues for Implantable Prostate Seedand Post-Operative Brachytherapy Markets forYears 2006, 2009 & 2015
- IV. COMPETITIVE LANDSCAPE
- Total Companies Profiled: 38 (including Divisions/Subsidiaries - 51)
- Region/Country Players
- The United States
- Canada
- Europe
- Germany
- The United Kingdom
- Italy
- Rest of Europe
- Asia-Pacific (Excluding Japan)
More Global Oncology/Hematology Reports
2012 Global CA Tumor Markers Diagnostics Market Outlook: Test Volumes, Sales Forecasts, and Supplier Shares by Country by
Venture Planning Group
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific ...
2012 World Cancer Diagnostic Market Overview: Facilities, Test Volumes, and Sales Forecasts by Country by
Venture Planning Group
This report provides a worldwide overview of the cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, ...
Cancer Pain Global Clinical Trials Review, H1, 2012 by
GlobalData
Cancer Pain Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Cancer Pain Global Clinical Trials Review, H1, 2012 provides data on the Cancer Pain ...
The 2012 Global Cancer Diagnostic Market Overview - Facilities, Test Volumes, and Sales Forecasts by Country by
Venture Planning Group
This report provides a worldwide overview of the cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, ...
World Market for Prescription Dermatological Drugs, 8th Edition (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments) by
Kalorama Information
This Kalorama Information report, The Worldwide Market for Prescription Dermatological Drugs represents the eighth time that Kalorama has detailed the various categories of prescription dermatological ...
See all reports like this >>
Share this report
Other tasks Related Markets Oncology/Hematology Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
